vs

Side-by-side financial comparison of FIRST COMMUNITY BANKSHARES INC (FCBC) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.

FIRST COMMUNITY BANKSHARES INC is the larger business by last-quarter revenue ($43.8M vs $38.3M, roughly 1.1× ImmunityBio, Inc.). FIRST COMMUNITY BANKSHARES INC runs the higher net margin — 28.5% vs -161.8%, a 190.3% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 5.1%). FIRST COMMUNITY BANKSHARES INC produced more free cash flow last quarter ($60.0M vs $-71.3M).

First Community Bankshares, Inc. is a $2.43 billion bank holding company and the parent company of First Community Bank of Bluefield, Virginia, in the United States. As of 2012 First Community Bank had 45 locations in Virginia, West Virginia, and North Carolina, and two locations operating as Peoples Community Bank in Tennessee. As of April 21, 2023, First Community had $3.6 billion in assets.

ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.

FCBC vs IBRX — Head-to-Head

Bigger by revenue
FCBC
FCBC
1.1× larger
FCBC
$43.8M
$38.3M
IBRX
Growing faster (revenue YoY)
IBRX
IBRX
+401.9% gap
IBRX
407.0%
5.1%
FCBC
Higher net margin
FCBC
FCBC
190.3% more per $
FCBC
28.5%
-161.8%
IBRX
More free cash flow
FCBC
FCBC
$131.3M more FCF
FCBC
$60.0M
$-71.3M
IBRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FCBC
FCBC
IBRX
IBRX
Revenue
$43.8M
$38.3M
Net Profit
$12.5M
$-61.9M
Gross Margin
99.0%
Operating Margin
36.8%
-169.0%
Net Margin
28.5%
-161.8%
Revenue YoY
5.1%
407.0%
Net Profit YoY
-4.4%
-4.7%
EPS (diluted)
$0.67
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FCBC
FCBC
IBRX
IBRX
Q4 25
$43.8M
$38.3M
Q3 25
$42.2M
$32.1M
Q2 25
$41.0M
$26.4M
Q1 25
$40.5M
$16.5M
Q4 24
$41.7M
$7.6M
Q3 24
$42.0M
$6.1M
Q2 24
$41.3M
Q1 24
$40.9M
Net Profit
FCBC
FCBC
IBRX
IBRX
Q4 25
$12.5M
$-61.9M
Q3 25
$12.3M
$-67.3M
Q2 25
$12.2M
$-92.6M
Q1 25
$11.8M
$-129.6M
Q4 24
$13.0M
$-59.2M
Q3 24
$13.0M
$-85.7M
Q2 24
$12.7M
Q1 24
$12.8M
Gross Margin
FCBC
FCBC
IBRX
IBRX
Q4 25
99.0%
Q3 25
99.4%
Q2 25
99.5%
Q1 25
99.6%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
FCBC
FCBC
IBRX
IBRX
Q4 25
36.8%
-169.0%
Q3 25
37.7%
-173.5%
Q2 25
38.6%
-269.8%
Q1 25
37.7%
-390.1%
Q4 24
39.6%
-919.0%
Q3 24
39.3%
-1314.3%
Q2 24
39.3%
Q1 24
40.3%
Net Margin
FCBC
FCBC
IBRX
IBRX
Q4 25
28.5%
-161.8%
Q3 25
29.1%
-209.8%
Q2 25
29.9%
-350.3%
Q1 25
29.2%
-784.9%
Q4 24
31.3%
-783.4%
Q3 24
31.0%
-1404.0%
Q2 24
30.8%
Q1 24
31.4%
EPS (diluted)
FCBC
FCBC
IBRX
IBRX
Q4 25
$0.67
$-0.06
Q3 25
$0.67
$-0.07
Q2 25
$0.67
$-0.10
Q1 25
$0.64
$-0.15
Q4 24
$0.67
$-0.08
Q3 24
$0.71
$-0.14
Q2 24
$0.71
Q1 24
$0.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FCBC
FCBC
IBRX
IBRX
Cash + ST InvestmentsLiquidity on hand
$242.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$500.5M
$-500.5M
Total Assets
$3.3B
$501.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FCBC
FCBC
IBRX
IBRX
Q4 25
$242.8M
Q3 25
$257.8M
Q2 25
$153.7M
Q1 25
$61.6M
Q4 24
$149.8M
Q3 24
$130.4M
Q2 24
Q1 24
Total Debt
FCBC
FCBC
IBRX
IBRX
Q4 25
Q3 25
$0
Q2 25
$0
Q1 25
$0
Q4 24
$0
Q3 24
$0
Q2 24
$0
Q1 24
$0
Stockholders' Equity
FCBC
FCBC
IBRX
IBRX
Q4 25
$500.5M
$-500.5M
Q3 25
$510.7M
$-524.3M
Q2 25
$502.8M
$-570.7M
Q1 25
$496.4M
$-591.4M
Q4 24
$526.4M
$-489.1M
Q3 24
$520.7M
$-745.1M
Q2 24
$508.9M
Q1 24
$506.9M
Total Assets
FCBC
FCBC
IBRX
IBRX
Q4 25
$3.3B
$501.9M
Q3 25
$3.2B
$519.0M
Q2 25
$3.2B
$402.1M
Q1 25
$3.2B
$303.8M
Q4 24
$3.3B
$382.9M
Q3 24
$3.2B
$364.6M
Q2 24
$3.2B
Q1 24
$3.2B
Debt / Equity
FCBC
FCBC
IBRX
IBRX
Q4 25
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FCBC
FCBC
IBRX
IBRX
Operating Cash FlowLast quarter
$62.7M
$-70.4M
Free Cash FlowOCF − Capex
$60.0M
$-71.3M
FCF MarginFCF / Revenue
137.0%
-186.2%
Capex IntensityCapex / Revenue
6.3%
2.4%
Cash ConversionOCF / Net Profit
5.03×
TTM Free Cash FlowTrailing 4 quarters
$100.6M
$-308.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FCBC
FCBC
IBRX
IBRX
Q4 25
$62.7M
$-70.4M
Q3 25
$18.9M
$-68.9M
Q2 25
$10.2M
$-79.7M
Q1 25
$13.2M
$-85.9M
Q4 24
$57.7M
$-85.1M
Q3 24
$11.4M
$-98.8M
Q2 24
$14.5M
Q1 24
$16.9M
Free Cash Flow
FCBC
FCBC
IBRX
IBRX
Q4 25
$60.0M
$-71.3M
Q3 25
$18.5M
$-69.6M
Q2 25
$10.0M
$-80.8M
Q1 25
$12.1M
$-87.0M
Q4 24
$54.9M
$-87.3M
Q3 24
$10.9M
$-101.6M
Q2 24
$14.1M
Q1 24
$15.2M
FCF Margin
FCBC
FCBC
IBRX
IBRX
Q4 25
137.0%
-186.2%
Q3 25
43.9%
-217.2%
Q2 25
24.3%
-305.9%
Q1 25
29.8%
-526.9%
Q4 24
131.8%
-1155.4%
Q3 24
26.0%
-1663.2%
Q2 24
34.1%
Q1 24
37.1%
Capex Intensity
FCBC
FCBC
IBRX
IBRX
Q4 25
6.3%
2.4%
Q3 25
1.0%
2.3%
Q2 25
0.6%
4.1%
Q1 25
2.8%
6.8%
Q4 24
6.7%
28.0%
Q3 24
1.2%
45.7%
Q2 24
0.9%
Q1 24
4.4%
Cash Conversion
FCBC
FCBC
IBRX
IBRX
Q4 25
5.03×
Q3 25
1.54×
Q2 25
0.83×
Q1 25
1.12×
Q4 24
4.43×
Q3 24
0.88×
Q2 24
1.14×
Q1 24
1.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons